Workflow
中医药
icon
Search documents
聚焦“两高四着力” 人大代表在行动丨给老百姓看好病 为人民群众发好声
He Nan Ri Bao· 2025-07-30 23:15
不到半小时,张景祖已经出现在李大娘家,并就她的病情给出诊疗意见。"张主任对病人热情周到,我 们遇到疑难杂症,总爱请教他。他几乎随叫随到,让这些行动不便的患者在家也能享受到高质量的医疗 服务。"张永军对此赞不绝口。 7月28日一早,长垣中西医结合医院古色古香的国医堂内,长垣市人大代表、主任中医师、河南省名中 医张景祖正在工作室给患者看诊。望闻问切,药香氤氲中,四诊合参已洞见症结。 今年3月底,全国基层名老中医药专家张景祖传承工作室揭牌暨拜师仪式举行,10多名青年医师拜张景 祖为师,为中医药行业注入新鲜血液。他在师训中道:学医先修德,应时刻谨记医德惟大,不可妄自菲 薄,贵利贱义。 "等吃完这几服药血糖稳下来,我给你抓个三五味药你当茶喝,既便宜又控糖降糖。"张景祖一边开方子 一边耐心跟患者交流…… 身为人大代表,张景祖常常利用坐诊、送医下乡等途径,广泛吸纳民意、汇集民智,并将群众的心声和 诉求转化为进一步改善民生、提升基层中医药服务能力等方面的意见建议。 忙忙碌碌一上午,快到午饭时间,张景祖的手机忽然响起。"李大娘最近胃口不好,头还晃得厉害,您 能来看看吗?"长垣市蒲西街道蒲光社区卫生室家庭医生张永军求助。他随访的 ...
上海农业科创谷总投资额已超200亿元
Xin Hua Cai Jing· 2025-07-30 14:46
Core Insights - Shanghai Agricultural Science and Technology Innovation Valley has achieved significant progress in its first year, with total investments exceeding 20 billion yuan, focusing on future industries such as plant extraction [1][2] - The establishment of the Yangtze River Delta Traditional Chinese Medicine Concept Verification and Achievement Transformation Center aims to enhance the conversion of TCM research into market-ready products, supported by national resources and partnerships with leading pharmaceutical companies [1] - The launch of the Shanghai Agricultural Science and Technology Innovation Valley Joint Innovation Center promotes the integration of academia, industry, and research, attracting new enterprises in smart equipment, biotechnology, and digital agriculture [2] Investment and Development - Total investment in the Shanghai Agricultural Science and Technology Innovation Valley has surpassed 20 billion yuan, indicating strong financial backing for agricultural innovation [1] - The initiative includes 31 major projects in plant extraction and aims to streamline the entire process from research and development to industrialization [1] Strategic Initiatives - The center will implement a dual support mechanism combining "verification assessment + resource integration" to facilitate the development of new TCM drugs and food products [1] - The "Four Batch" project aims to establish significant technological infrastructure, publish technology lists, form industry innovation coalitions, and launch high-value plant extraction products [2]
好医生集团董事长耿福能获评“全国非公有制经济人士优秀中国特色社会主义事业建设者”
Zhong Guo Jing Ji Wang· 2025-07-30 09:53
Core Viewpoint - The sixth National Excellent Builders of Socialism with Chinese Characteristics for Non-Public Economic Persons award ceremony recognized outstanding contributions in economic development, technological innovation, and social responsibility, with Jiang Fuhua of Good Doctor Group being honored for his leadership and contributions to the traditional Chinese medicine industry and rural revitalization [2][3]. Group 1: Award and Recognition - The award was jointly organized by several government departments, aiming to honor non-public economic figures who have made significant contributions to economic and social development [3]. - A total of 100 "Excellent Builders" were selected, with Jiang Fuhua representing the pharmaceutical industry [3]. Group 2: Company Overview - Good Doctor Group, under Jiang Fuhua's leadership, has been recognized as one of the "Top 100 Pharmaceutical Enterprises in China" for 14 consecutive years, evolving into a large enterprise group with a focus on biomedicine [3]. - The company operates across various sectors, including pharmaceutical manufacturing, commerce, research and development, healthcare, and modern agricultural processing, employing over 20,000 people [3]. Group 3: Contributions to Traditional Chinese Medicine - Jiang Fuhua has actively promoted traditional Chinese medicine, establishing national-level research platforms and expanding innovative drug projects [4]. - The company has developed 13 innovative drug projects and 12 generic drug projects, collaborating with renowned universities and undertaking over 100 national and provincial research projects [4]. Group 4: Rural Revitalization and Poverty Alleviation - Since 1996, the company has focused on poverty alleviation in Liangshan Prefecture, Sichuan Province, promoting the cultivation of traditional Chinese medicinal herbs [5]. - In 2024, the company facilitated the cultivation of 33,800 acres of medicinal herbs across 9 counties in Sichuan, with a total national planting area of 65,400 acres [5]. - An investment of 110 million yuan was made to build a modern processing plant for medicinal herbs, benefiting over 147,000 farmers and laying a foundation for rural revitalization [5].
破局中药创新深水区:以岭药业五年五新药的战略跃迁
Zheng Quan Zhi Xing· 2025-07-30 09:05
Core Viewpoint - The article highlights the significant achievements of Yiling Pharmaceutical in the Chinese traditional medicine sector over the past five years, particularly its innovative drug development and successful market entries, marking a notable acceleration in the industry [2][4]. Group 1: Product Launches and Innovations - Yiling Pharmaceutical's proprietary traditional Chinese medicine, Qifang Bitong Pian, has been successfully registered and launched in Macau, becoming the first innovative traditional Chinese medicine approved in the region [2][3]. - Over the past five years, Yiling has launched five innovative traditional Chinese medicines, averaging one new drug per year, which is significantly higher than the industry average of less than ten new drugs annually [4][5]. - The company has a robust pipeline with two traditional medicines already submitted for production approval, six in clinical stages, and over a hundred hospital preparations as potential new drug candidates [5][6]. Group 2: Strategic Positioning and Market Expansion - Yiling's product strategy focuses on creating a comprehensive "big respiratory" product matrix that addresses multiple respiratory diseases, enhancing its market position [6][7]. - The company has expanded its focus from traditional respiratory treatments to include mental health products, responding to the growing demand for solutions to emotional and psychological issues [8][9]. - The launch of Tongluo Mingmu Capsules demonstrates the application of Yiling's "Luo Disease Theory" in treating complications related to diabetes, showcasing the versatility of traditional Chinese medicine in modern healthcare [9][10]. Group 3: Future Outlook and Business Strategy - Yiling Pharmaceutical is not only advancing its traditional Chinese medicine business but is also actively developing biopharmaceuticals and health products, creating a diversified portfolio that meets various consumer needs [11][12]. - The company aims to establish a new development pattern that integrates traditional Chinese medicine, biopharmaceuticals, and health industries, positioning itself as a comprehensive health solution provider [12].
以岭药业将可持续发展理念贯穿企业发展全过程
Zhong Guo Jing Ji Wang· 2025-07-28 05:27
Core Viewpoint - Yiling Pharmaceutical, as a leading enterprise in the traditional Chinese medicine industry, integrates sustainable development concepts throughout its operations, focusing on environmental, social, and governance responsibilities to promote harmonious coexistence with society and the environment [1][2]. Group 1: Innovation and Product Development - Yiling Pharmaceutical adheres to the principle of "inheritance and innovation for the benefit of humanity," continuously innovating based on clinical needs and leveraging its strong innovation capabilities to make traditional Chinese medicine accessible and effective [1]. - By the end of 2024, the company has developed and launched 17 innovative patented traditional Chinese medicines, covering areas such as cardiovascular, respiratory, oncology, urology, and mental health, with 11 included in the national medical insurance catalog and 5 in the national essential drug list [1]. - The company has established a new model for rural revitalization through its "four drives and one push" strategy, enhancing the quality of raw materials and providing tangible benefits to local communities [1]. Group 2: Employee Development and Social Responsibility - Yiling Pharmaceutical emphasizes that talent is the primary resource, ensuring employee rights and focusing on their growth and development, with a training investment of 17.807 million yuan in 2024, achieving a 100% training coverage rate [2]. - The company actively engages in public welfare, supporting disaster relief efforts by donating medicines and materials to affected areas and establishing a health fund for physicians [2]. Group 3: Corporate Governance and Environmental Initiatives - Yiling Pharmaceutical continuously enhances its corporate governance capabilities, strengthens board construction, and improves risk management and internal controls to support sustainable development [2]. - In 2024, the company invested 1.9013 million yuan in environmental protection, optimizing energy usage efficiency and achieving a photovoltaic power generation of 3.02 million kWh, saving 964,000 yuan in electricity costs [3]. - The company was recognized as a "Green Factory" in Hebei Province and included in the provincial green manufacturing list, demonstrating its commitment to ecological protection and sustainable practices [3].
“佛门CEO”释永信被查,方丈的商业版图究竟有多大?
创业邦· 2025-07-28 03:05
Core Viewpoint - The article discusses the recent investigation of the abbot of Shaolin Temple, Shi Yongxin, for alleged criminal activities, including misappropriation of funds and inappropriate relationships, which raises questions about the commercialization of the temple and its impact on its spiritual integrity [3][9][28]. Group 1: Background and Development of Shaolin Temple - Shi Yongxin has been the abbot for 26 years, transforming Shaolin Temple from a dilapidated site into a commercial empire spanning various industries such as culture, tourism, and food [9][15]. - The temple's commercialization began with the recognition and protection of its cultural value, leading to the establishment of the Henan Shaolin Intangible Asset Management Company in 2008 [17][21]. Group 2: Commercialization Strategies - The temple has developed a diverse range of business operations, including cultural tourism, intellectual property management, and health industries, creating a unique "religion + business" model [21][24]. - In 2010, tourism revenue from Shaolin Temple accounted for one-third of the local government's income, with ticket sales and related experiences generating significant financial returns [22]. Group 3: Financial Performance and Market Expansion - In 2019, the peak visitor count reached 4.2 million, generating over 1.2 billion yuan in total revenue based on an average spending of 300 yuan per visitor [22]. - The temple's e-commerce initiatives, such as the "Shaolin Happy Land" store on Taobao, have seen sales grow from hundreds of thousands to 23 million yuan by 2020 [25]. Group 4: Controversies and Challenges - The commercialization has led to public scrutiny regarding the temple's spiritual integrity, with rising ticket prices and significant investments in commercial real estate raising concerns about its original purpose [28][32]. - Allegations against Shi Yongxin, including claims of inappropriate relationships and financial misconduct, have sparked debates about the balance between faith and profit [28][32].
北京推动中医药与数字技术融合发展
Bei Jing Qing Nian Bao· 2025-07-25 01:01
Group 1 - The Boao Forum for Asia Global Health Forum 2025 was inaugurated in Beijing, focusing on the theme "The New Future of the Health Industry Driven by Innovation" [1] - A sub-forum on "The Development of Traditional Medicine in the Context of Innovation" discussed the integration of traditional medicine with digital technology [1] - Beijing is promoting the integration of artificial intelligence and big data with traditional Chinese medicine, supported by policies such as the "Data Element × Implementation Plan" and "Artificial Intelligence + Medicine and Health" [1] Group 2 - Traditional Chinese medicine has spread to over 190 countries and regions, with acupuncture and treatment methods widely accepted [2] - The global market for traditional Chinese medicine is projected to reach $185.7 billion by 2028, indicating significant market potential [2] - Traditional medicine is expected to achieve scientific validation and value enhancement globally, contributing to a more inclusive and sustainable global health system [2]
北京中医医院院长刘清泉:想用人工智能“复活”孙思邈
Jing Ji Guan Cha Wang· 2025-07-24 12:23
Group 1 - The core idea is the exploration of using artificial intelligence to "revive" ancient Chinese medicine practitioners, enabling their knowledge and diagnostic methods to assist modern medical professionals [2][3] - Beijing Traditional Chinese Medicine Hospital is training AI models based on the clinical problem-solving approaches of renowned old Chinese medicine doctors to aid younger doctors in diagnosis and treatment [2] - The hospital is in discussions with major companies like Alibaba to potentially recreate the expertise of famous skin doctor Zhao Bingnan for academic exploration and disease diagnosis [2] Group 2 - The integration of AI into traditional Chinese medicine could enhance the "living inheritance" of knowledge, allowing for a more extensive and effective approach to disease treatment compared to individual practitioners [3] - The development of traditional Chinese medicine must incorporate modern technology and scientific advancements to avoid falling behind in the evolving medical landscape [3] - There is a call for interdisciplinary talents who understand both traditional Chinese medicine and modern medical practices, as well as the application of AI and other technologies for standardized research [3]
河南开封综保区:“四区叠加”赋能企业“买卖全球”
Group 1 - The Kaifeng Comprehensive Bonded Zone achieved a total import and export volume of 7.637 billion yuan in the first half of the year, representing a year-on-year growth of 128%, leading Henan province in growth rate [1] - The zone serves as a "test field" for reform and opening up, where the stories of enterprise development intertwine with innovative services, illustrating a vibrant picture of high-quality foreign trade development [1] Group 2 - Qianchaotang (Henan) Traditional Chinese Medicine Products Co., Ltd. has become a leader in the export of Chinese medicine, with over 3,200 foreign trade orders in the first half of the year, 78% of which were from Russia and Central Asia [2] - The company has invested 60 million yuan to establish a Chinese medicine material testing center in collaboration with Henan University, ensuring quality control from the source [2] - Qianchaotang is actively participating in overseas professional exhibitions and preparing to build an overseas e-commerce platform to enhance market expansion [2] Group 3 - Yumi International Bonded Warehouse reported an import and export volume exceeding 150 million yuan in the first half of the year, with expectations to reach 300 million to 500 million yuan by the end of the year [3] - The bonded model in the zone reduces costs, allowing consumers to enjoy more affordable imported wines [3] Group 4 - The development of enterprises in the Kaifeng Comprehensive Bonded Zone is supported by strong policy backing, being the only "four-zone overlap" open platform in Henan, integrating various national-level initiatives [4] - The zone has established a "one enterprise, one policy" service mechanism and improved customs clearance efficiency, enhancing the overall operational environment for businesses [4] - Policies such as 24/7 customs service and expedited export tax refunds have increased cargo turnover efficiency by 40%, benefiting companies like Qianchaotang [4] Group 5 - The one-stop service in the bonded zone allows companies to operate with ease, facilitating urgent orders and seasonal shipments through convenient customs policies [5] - The zone aims to achieve an annual import and export volume exceeding 10 billion yuan and enter the B-class category of national bonded zones [6] - Future plans include enhancing trade convenience and attracting more enterprises to settle in the zone, leveraging its logistics advantages [6]
中医夜市圈粉中国年轻人
Xin Hua Wang· 2025-07-23 18:30
Core Viewpoint - The rise of traditional Chinese medicine (TCM) night markets is attracting a growing number of young people in China, showcasing a blend of cultural heritage and modern lifestyle choices [1][2][5]. Group 1: Market Trends - TCM night markets have become popular in various cities across China, particularly during the summer evenings, with activities such as pulse diagnosis, cupping therapy, and herbal tea tasting [1][5]. - In Baiyin City, Gansu Province, the TCM night market has seen an average daily attendance of over 2,000 visitors since its opening in early July [5]. Group 2: Young People's Engagement - Young individuals are increasingly interested in TCM, with many seeking to understand and utilize traditional practices for health benefits [2][5]. - Medical professionals are encouraging young people to explore TCM literature, such as "Huangdi Neijing" and "Bencao Gangmu," to deepen their knowledge and practice [2]. Group 3: Health Services and Innovations - The night markets feature free health consultations from over 30 local medical institutions, providing health advice and promoting TCM wellness knowledge [5]. - Various innovative elements are being introduced in TCM night markets, including modern technology like thermal moxibustion robots and 3D foot measurement devices, enhancing the overall experience [5].